Quarterly report pursuant to Section 13 or 15(d)

STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

v2.4.0.6
STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Total
Beginning balance, value at Dec. 31, 2011 $ 700 $ 59,800 $ (98,605) $ (38,105)
Beginning balance, shares at Dec. 31, 2011 7,000,000      
Forgiveness of shareholder advances   83,647   83,647
Net Income/Loss     (45,611) (45,611)
Ending balance, value at Dec. 31, 2012 700 143,447 (144,216) (69)
Beginning balance, shares at Dec. 31, 2012 7,000,000      
Forgiveness of shareholder advances   83,647    
Shares issued for first installment of PhytoSphere Agreement, shares 900,000      
Shares issued for first installment of PhytoSphere Agreement, value 90 4,499,910   4,500,000
Net Income/Loss       377,941 337,941
Ending balance, value at Mar. 31, 2013 $ 790 $ 4,643,357 $ 193,725 $ 4,837,872
Ending balance, shares at Mar. 31, 2013 7,900,000